{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:42Z","timestamp":1791295722905,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bpg.2012.01.007","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T03:57:45Z","timestamp":1335326265000},"page":"197-206","source":"Crossref","is-referenced-by-count":22,"title":["Aspirin and NSAIDs; benefits and harms for the gut"],"prefix":"10.1016","volume":"26","author":[{"given":"Prarthana","family":"Thiagarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz A.","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2012.01.007_bib2","series-title":"GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide","author":"Ferlay","year":"2010"},{"key":"10.1016\/j.bpg.2012.01.007_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semradonc.2006.09.003","article-title":"Epidemiology and pathogenesis of esophageal cancer","volume":"17","author":"Holmes","year":"2007","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"10.1016\/j.bpg.2012.01.007_bib4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L","article-title":"Demographic variations in the rising incidence of esophageal adenocarcinoma in white males","volume":"92","author":"Bollschweiler","year":"2001","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.bpg.2012.01.007_bib5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4065\/83.10.1087","article-title":"Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study","volume":"83","author":"Crane","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.bpg.2012.01.007_bib6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/CIRCULATIONAHA.110.963843","article-title":"Contemporary reviews in cardiovascular medicine","volume":"123","author":"Fuster","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bpg.2012.01.007_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.20452\/pamw.981","article-title":"Aspirin chemoprevention of gastrointestinal cancer in the next decade. A review of the evidence","volume":"120","author":"Jankowska","year":"2010","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.bpg.2012.01.007_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2407-3-28","article-title":"Effects of nonsteroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis","volume":"3","author":"Gonzalez-Perez","year":"2003","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bpg.2012.01.007_bib9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","article-title":"Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett\u2019s oesophagus: a prospective study","volume":"6","author":"Vaughan","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpg.2012.01.007_bib10","first-page":"97","article-title":"Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer","volume":"7","author":"Farrow","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpg.2012.01.007_bib11","first-page":"CD004079","article-title":"Non steroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas","volume":"2","author":"Asano","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.bpg.2012.01.007_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jnci\/djn484","article-title":"Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study","volume":"101","author":"Grau","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"9573","key":"10.1016\/j.bpg.2012.01.007_bib13","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.bpg.2012.01.007_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14320","article-title":"Chemoprevention of colorectal cancer: systematic review and economic evaluation","volume":"14","author":"Cooper","year":"2010","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.bpg.2012.01.007_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.giec.2010.09.005","article-title":"Chemoprevention in Barrett\u2019s esophagus: a pill a day?","volume":"21","author":"Jankowski","year":"2011","journal-title":"Gastrointest Endosc Clin N Am."},{"issue":"9","key":"10.1016\/j.bpg.2012.01.007_bib16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cgh.2011.05.020","article-title":"Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis","volume":"9","author":"Lanas","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2012.01.007_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.amjmed.2010.12.022","article-title":"Long-term use of aspirin and the risk of gastrointestinal bleeding","volume":"124","author":"Huang","year":"2011","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.bpg.2012.01.007_bib18","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/art.21887","article-title":"Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk","volume":"54","author":"Solomon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpg.2012.01.007_bib19","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Metaanalysis of randomized trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.bpg.2012.01.007_bib20","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jama.280.22.1930","article-title":"Aspirin and risk of hemorrhagic stroke: a metaanalysis of randomized control trials","volume":"280","author":"He","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bpg.2012.01.007_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.STR.0000196991.03618.31","article-title":"Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death","volume":"37","author":"Saloheimo","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.bpg.2012.01.007_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajh.10451","article-title":"Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials","volume":"75","author":"Serebruany","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bpg.2012.01.007_bib23","doi-asserted-by":"crossref","unstructured":"de Jong PT, Chakravarthy U, Rahu M, Seland J, Soubrane G, Topouzis F, et\u00a0al. Associations between aspirin use and aging macula disorder the European Eye study. Ophthalmology; 2011 Sep 13. Epub ahead of print.","DOI":"10.1016\/j.ophtha.2011.06.025"},{"issue":"12","key":"10.1016\/j.bpg.2012.01.007_bib24","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.ophtha.2009.05.031","article-title":"Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women","volume":"116","author":"Christen","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bpg.2012.01.007_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.328.7437.434","article-title":"Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice","volume":"328","author":"Jenkins","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.bpg.2012.01.007_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/HPC.0b013e318213d5a6","article-title":"Outpatient aspirin desensitization for patients with aspirin hypersensitivity and cardiac disease","volume":"10","author":"Fajt","year":"2011","journal-title":"Crit Pathw Cardiol"},{"issue":"1-3","key":"10.1016\/j.bpg.2012.01.007_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2005.12.053","article-title":"The broken balance in aspirin hypersensitivity","volume":"533","author":"Szczeklik","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bpg.2012.01.007_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1398-9995.1980.tb01730.x","article-title":"Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review","volume":"35","author":"Settipane","year":"1980","journal-title":"Allergy"},{"key":"10.1016\/j.bpg.2012.01.007_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2230.2003.01228.x","article-title":"Aspirin sensitivity and urticaria","volume":"28","author":"Grattan","year":"2003","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.bpg.2012.01.007_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3346\/jkms.2005.20.3.367","article-title":"Polymorphisms of high-affinity IgE receptor and histamine-related genes in patients with ASA-induced urticaria\/angioedema","volume":"20","author":"Choi","year":"2005","journal-title":"J Korean Med Sci"},{"issue":"6","key":"10.1016\/j.bpg.2012.01.007_bib31","first-page":"699","article-title":"Analysis of 76 patients with urticaria and angioedema induced by non-steroidal anti-inflammatory drugs (NSAIDs) in Japan","volume":"60","author":"Moriya","year":"2011","journal-title":"Arerugi"},{"issue":"3","key":"10.1016\/j.bpg.2012.01.007_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pediatrneurol.2008.06.003","article-title":"Reye syndrome and reye-like syndrome","volume":"39","author":"Gosalakkal","year":"2008","journal-title":"Pediatr Neurol"},{"issue":"10","key":"10.1016\/j.bpg.2012.01.007_bib33","first-page":"679","article-title":"Renal effects of low dose aspirin in elderly patients","volume":"8","author":"Segal","year":"2006","journal-title":"Isr Med Assoc J"},{"issue":"11","key":"10.1016\/j.bpg.2012.01.007_bib34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/qjmed\/hcg138","article-title":"Hepatocellular damage from non-steroidal anti-inflammatory drugs","volume":"96","author":"O\u2019Connor","year":"2003","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.bpg.2012.01.007_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cld.2007.06.004","article-title":"Nonsteroidal anti-inflammatory drug-induced hepatotoxicity","volume":"11","author":"Aithal","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.bpg.2012.01.007_bib36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0022-3565(24)35379-0","article-title":"Possible mechanisms of hepatocyte injury induced by diphenylamine and its structurally related NSAIDS","volume":"292","author":"Masubuchi","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.bpg.2012.01.007_bib37","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/j.1572-0241.2008.01995.x","article-title":"Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin","volume":"103","author":"Yeomans","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.bpg.2012.01.007_bib38","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2005.02444.x","article-title":"Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users","volume":"21","author":"Vergara","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.bpg.2012.01.007_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1523-5378.2007.00543.x","article-title":"Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial","volume":"12","author":"de Leest","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.bpg.2012.01.007_bib40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0149-2918(00)88318-6","article-title":"Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers","volume":"21","author":"Agrawal","year":"1999","journal-title":"Clin Ther"},{"issue":"8","key":"10.1016\/j.bpg.2012.01.007_bib41","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3346\/jkms.2011.26.8.1074","article-title":"Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol","volume":"26","author":"Lee","year":"2011","journal-title":"J Korean Med Sci."},{"issue":"9754","key":"10.1016\/j.bpg.2012.01.007_bib42","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2012.01.007_bib43","unstructured":"Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et\u00a0al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet; 2011 Oct 27. Epub ahead of print."},{"issue":"3","key":"10.1016\/j.bpg.2012.01.007_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2036.2007.03380.x","article-title":"Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis","volume":"26","author":"DuPont","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.bpg.2012.01.007_bib45","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.clinthera.2011.07.009","article-title":"Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer","volume":"33","author":"Squires","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.bpg.2012.01.007_bib46","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1111\/j.1572-0241.2008.02117.x","article-title":"Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett\u2019s esophagus","volume":"103","author":"Hur","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.01.007_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-540-69297-3_15","article-title":"Chemoprevention of esophageal cancer and the AspECT trial","volume":"181","author":"Das","year":"2009","journal-title":"Recent Results Cancer Res"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169181200008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169181200008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T16:04:43Z","timestamp":1743005083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169181200008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S152169181200008X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2012.01.007","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}